Annual Cash & Cash Equivalents
$27.44 M
-$4.56 M-14.26%
31 December 2023
Summary:
Journey Medical annual cash & cash equivalents is currently $27.44 million, with the most recent change of -$4.56 million (-14.26%) on 31 December 2023. During the last 3 years, it has risen by +$19.19 million (+232.76%). DERM annual cash & cash equivalents is now -90.73% below its all-time high of $295.92 million, reached on 31 December 2017.DERM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$22.46 M
-$1.45 M-6.07%
30 September 2024
Summary:
Journey Medical quarterly cash and cash equivalents is currently $22.46 million, with the most recent change of -$1.45 million (-6.07%) on 30 September 2024. Over the past year, it has dropped by -$2.29 million (-9.24%). DERM quarterly cash and cash equivalents is now -54.24% below its all-time high of $49.08 million, reached on 31 December 2021.DERM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DERM Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.3% | -9.2% |
| 3 y3 years | +232.8% | +3.6% |
| 5 y5 years | -73.9% | - |
DERM Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -44.1% | +232.8% | -54.2% | +172.9% |
| 5 y | 5 years | -73.9% | +471.5% | -54.2% | +172.9% |
| alltime | all time | -90.7% | +471.5% | -54.2% | +172.9% |
Journey Medical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $22.46 M(-6.1%) |
| June 2024 | - | $23.91 M(-0.6%) |
| Mar 2024 | - | $24.06 M(-12.3%) |
| Dec 2023 | $27.44 M(-14.3%) | $27.44 M(+10.9%) |
| Sept 2023 | - | $24.75 M(+200.7%) |
| June 2023 | - | $8.23 M(-52.6%) |
| Mar 2023 | - | $17.35 M(-45.8%) |
| Dec 2022 | $32.00 M(-34.8%) | $32.00 M(-8.3%) |
| Sept 2022 | - | $34.89 M(-8.5%) |
| June 2022 | - | $38.14 M(-7.7%) |
| Mar 2022 | - | $41.33 M(-15.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $49.08 M(+495.2%) | $49.08 M(+126.3%) |
| Sept 2021 | - | $21.69 M(+78.1%) |
| June 2021 | - | $12.18 M(+47.7%) |
| Dec 2020 | $8.25 M(+71.8%) | $8.25 M |
| Dec 2019 | $4.80 M(-95.4%) | - |
| Dec 2018 | $104.98 M(-64.5%) | - |
| Dec 2017 | $295.92 M(+608.1%) | - |
| Dec 2016 | $41.79 M(-61.0%) | - |
| Dec 2015 | $107.24 M(+93.7%) | - |
| Dec 2014 | $55.36 M(+150.0%) | - |
| Dec 2013 | $22.14 M(+181.3%) | - |
| Dec 2012 | $7.87 M | - |
FAQ
- What is Journey Medical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Journey Medical?
- What is Journey Medical annual cash & cash equivalents year-on-year change?
- What is Journey Medical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Journey Medical?
- What is Journey Medical quarterly cash and cash equivalents year-on-year change?
What is Journey Medical annual cash & cash equivalents?
The current annual cash & cash equivalents of DERM is $27.44 M
What is the all time high annual cash & cash equivalents for Journey Medical?
Journey Medical all-time high annual cash & cash equivalents is $295.92 M
What is Journey Medical annual cash & cash equivalents year-on-year change?
Over the past year, DERM annual cash & cash equivalents has changed by -$4.56 M (-14.26%)
What is Journey Medical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of DERM is $22.46 M
What is the all time high quarterly cash and cash equivalents for Journey Medical?
Journey Medical all-time high quarterly cash and cash equivalents is $49.08 M
What is Journey Medical quarterly cash and cash equivalents year-on-year change?
Over the past year, DERM quarterly cash and cash equivalents has changed by -$2.29 M (-9.24%)